Cargando…

51 Outcomes after SARS-CoV-2 infection in Canadians with cystic fibrosis: Analyses using the Canadian Cystic Fibrosis Registry

Detalles Bibliográficos
Autores principales:	Cheng, S., Le, T., Wallenburg, J., Sykes, J., Stephenson, A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	European Cystic Fibrosis Society. 2022
Materias:	Posters
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9527889/ http://dx.doi.org/10.1016/S1569-1993(22)00742-1

Ejemplares similares

44: Characterizing the COVID-19 pandemic among Canadians living with cystic fibrosis: A Canadian Cystic Fibrosis Registry study
por: Cheng, S., et al.
Publicado: (2021)

37 Trends in Canadian cystic fibrosis health care use amidst the COVID-19 pandemic
por: Le, T., et al.
Publicado: (2022)

P084 The impact of the SARS-CoV-2 pandemic on people living with cystic fibrosis in Ireland: real-world data from the Irish cystic fibrosis registry
por: Rees, H., et al.
Publicado: (2021)

490: A prospective study to evaluate serologic and immune responses to SARS-COV-2 infection in persons living with cystic fibrosis: Canadian arm of the CAR-CF study
por: Blanchard, A., et al.
Publicado: (2021)

Genomic epidemiology of Mycobacterium abscessus in a Canadian cystic fibrosis centre
por: Waglechner, Nicholas, et al.
Publicado: (2022)

P163 Effects of the SARS-CoV-2 pandemic on attendance at the cystic fibrosis centre and the definition of the microbiological status of cystic fibrosis patients in Tuscany
por: Dolce, D., et al.
Publicado: (2021)

Glucose tolerance in Canadian and French cystic fibrosis adult patients
por: Reynaud, Quitterie, et al.
Publicado: (2019)

159: Lung function changes following Sars-CoV-2 infection in cystic fibrosis
por: Kremer, T., et al.
Publicado: (2021)

First and second wave of SARS-CoV2 in Italian Cystic Fibrosis patients: Data from Italian Cystic Fibrosis Registry
por: Padoan, Rita, et al.
Publicado: (2021)

25: Seroprevalence and clinical characteristics of SARS-CoV-2 infection in children and adolescents with cystic fibrosis
por: Hergenroeder, G., et al.
Publicado: (2021)

Osteoporosis in Canadian adult cystic fibrosis patients: A descriptive study
por: Brenckmann, Christine, et al.
Publicado: (2003)

P135 SARS-COV-2 infection in patients with cystic fibrosis
por: Balanetchi, L., et al.
Publicado: (2021)

235: COVID-19 vaccination in individuals with cystic fibrosis at a pediatric cystic fibrosis center
por: Elson, E., et al.
Publicado: (2021)

385 Mechanisms by which cystic fibrosis transmembrane conductance regulator may influence SARS-CoV-2 infection
por: Tedbury, P., et al.
Publicado: (2022)

382: SARS-CoV-2 induces distinct inflammatory signals in cystic fibrosis macrophages that are seduced by resolvins
por: Recchiuti, A., et al.
Publicado: (2021)

P083 Clinical progression of SARS-CoV-2 infection in people with cystic fibrosis: a global observational study
por: McClenaghan, E., et al.
Publicado: (2021)

Cystic Fibrosis Screen Positive, Inconclusive Diagnosis Genotypes in the Cystic Fibrosis Registry
por: Thompson, Cassandra, et al.
Publicado: (2023)

509 Cystic fibrosis transmembrane conductance regulator positively regulates angiotensin-converting enzyme 2 expression and SARS-CoV-2 viral entry into airway epithelial cells: Implications for patients with cystic fibrosis
por: Bezzerri, V., et al.
Publicado: (2022)

27 Effect of SARS-CoV-2 on long-term physical and mental health symptoms in people with cystic fibrosis and their caregivers
por: Hudock, K., et al.
Publicado: (2022)

The Canadian Registry for Pulmonary Fibrosis: Design and Rationale of a National Pulmonary Fibrosis Registry
por: Ryerson, Christopher J., et al.
Publicado: (2016)

343: Impact of the SARS-CoV-2 pandemic and a food pantry on food insecurity in a pediatric cystic fibrosis center
por: Holzum, H., et al.
Publicado: (2021)

The global impact of SARS-CoV-2 in 181 people with cystic fibrosis
por: McClenaghan, Elliot, et al.
Publicado: (2020)

SARS-CoV-2 Infection in patients with cystic fibrosis. An overwiew
por: Fainardi, Valentina, et al.
Publicado: (2020)

Baseline characteristics and comorbidities in the CAnadian REgistry for Pulmonary Fibrosis
por: Fisher, J. H., et al.
Publicado: (2019)

External validity of machine learning-based prognostic scores for cystic fibrosis: A retrospective study using the UK and Canadian registries
por: Qin, Yuchao, et al.
Publicado: (2023)

Comparison of quadriceps muscle size and quality in adults with cystic fibrosis with different severities of cystic fibrosis transmembrane conductance regulator protein dysfunction
por: Wu, Kenneth, et al.
Publicado: (2022)

The Equitable Implementation of Cystic Fibrosis Personalized Medicines in Canada
por: Shemie, Genevieve, et al.
Publicado: (2021)

Cystic Fibrosis Mortality in Childhood. Data from European Cystic Fibrosis Society Patient Registry
por: Zolin, Anna, et al.
Publicado: (2018)

P072 SARS-CoV-2 infection in patients with cystic fibrosis (CF) - a single centre experience
por: Vidoevska, A., et al.
Publicado: (2022)

P214 Clinical course of SARS-CoV-2 infections of paediatric patients with cystic fibrosis– a single retrospective centre experience
por: Sieber, J., et al.
Publicado: (2023)

485 Chronic sequelae of SARS-CoV-2 in the Scnn1b-Tg mouse model of cystic fibrosis lung disease
por: Hawkins, P., et al.
Publicado: (2022)

Longitudinal analysis of vertebral fracture and BMD in a Canadian cohort of adult cystic fibrosis patients
por: Papaioannou, Alexandra, et al.
Publicado: (2008)

Longitudinal analysis of vertebral fracture and BMD in a Canadian cohort of adult cystic fibrosis patients
por: Papaioannou, Alexandra, et al.
Publicado: (2008)

433: Rationale and design of an international multicenter prospective study to evaluate serologic immune responses to SARS-CoV-2 infection in persons living with cystic fibrosis: The CAR-CF study
por: Hernandez, R., et al.
Publicado: (2021)

Crosslink between SARS-CoV-2 replication and cystic fibrosis hallmarks
por: Lotti, Virginia, et al.
Publicado: (2023)

A multinational report to characterise SARS-CoV-2 infection in people with cystic fibrosis
por: Cosgriff, Rebecca, et al.
Publicado: (2020)

439 Cystic fibrosis transmembrane conductance regulator impairment strongly decreases SARS-CoV-2 replication in human bronchial epithelial cells
por: Sorio, C., et al.
Publicado: (2022)

Systematic review: cystic fibrosis in the SARS-CoV-2/COVID-19 pandemic
por: Mathew, Hannah R., et al.
Publicado: (2021)

Cystic Fibrosis
por: Dodge, J A
Publicado: (1997)

P220 Experiences of virtual cystic fibrosis clinics during the COVID-19 pandemic at one UK adult cystic fibrosis centre
por: Warnock, L., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_fc2vslbg0s6l0v52l1l5cikemq